Galapagos NV

(GLPGF)

By |

Profile

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact Information

Website: www.glpg.com
Email: ir@glpg.com
Main Phone: +32 15342900
Address: Generaal De Wittelaan L11 A3
City / Town: Mechelen
Country: BE
Postal Code: 2800

Issuer Information

Exchange: GREY
CEO: Onno van de Stolpe
Employees: 1280

Equities News

Profile

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact Information

Website: www.glpg.com
Email: ir@glpg.com
Main Phone: +32 15342900
Address: Generaal De Wittelaan L11 A3
City / Town: Mechelen
Country: BE
Postal Code: 2800

Issuer Information

Exchange: GREY
CEO: Onno van de Stolpe
Employees: 1280

Equities News

$ 125.00 $ 4.25 (3.52%)
Last Price 125.00 Change $ 4.25 Change % 3.52 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 125.00 High 125.00 Low 125.00 Prev Close 120.75
Last Trade Volume 13 52 Wk Hi 268.66 52 Wk Low 114.00
Market Cap 8.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 65,340,842.00 EPS (TTM) -0.81 PE Ratio -18.50 Exchange Greys